Pfizer’s Capsugel sales to KKR for $2.4 bn raises speculation on other divestment
05 April 2011
Nancy Faigen
Please Login to read the full article.
05 April 2011
Nancy Faigen
Nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- How is the eurocrisis hitting pharma and what are the risks?
- "Welcome home": Stromedix buy brings fibrosis drug back to Biogen
- Novartis buys Fougera for $1.5 billion cash to boost Sandoz dermatology business
- Amylin and Bristol-Myers Squibb deny reports that Amylin rejected $3.5 billion offer
COMMENT
Other Informa Comment
FEATURES
- Interview: Adimab's Gerngross seeks two sweethearts
- Merck BioVentures: where biosimilars make a difference
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
